Tumor necrosis factor, tumor necrosis factor inhibition, and cancer risk.

Lebrec, Hervé; Ponce, Rafael; Preston, Bradley D; Iles, Jan; Born, Teresa L; Hooper, Michele

Lebrec, Hervé; Ponce, Rafael; Preston, Bradley D; Iles, Jan; Born, Teresa L; Hooper, Michele.

Affiliation

Lebrec H; Amgen Inc. , Thousand Oaks, CA , USA.

Curr Med Res Opin ; 31(3): 557-74, 2015 Mar.

Article in En | MEDLINE | ID: mdl-25651481

Subject(s)

Arthritis, Rheumatoid/immunology; Inflammation/immunology; Neoplasms; Tumor Necrosis Factors; Animals; Disease Models, Animal; Humans; Neoplasm Recurrence, Local/metabolism; Neoplasms/immunology; Neoplasms/metabolism; Risk Factors; Signal Transduction; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factors/metabolism

Key words

Cancer; Inflammation; Malignancy; TNF; TNF inhibition; Tumor

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Arthritis, Rheumatoid / Tumor Necrosis Factors / Inflammation / Neoplasms Type of study: Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Animals / Humans Language: En Journal: Curr Med Res Opin Year: 2015 Document type: Article Affiliation country: United States Country of publication: United kingdom

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google